Proactiveinvestors USA & Canada Algernon Pharmaceuticals Inc. https://ca.proactiveinvestors.com Proactiveinvestors USA & Canada Algernon Pharmaceuticals Inc. RSS feed en Wed, 27 Jan 2021 19:14:41 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) NA Proactive news snapshot: CleanSpark, International Montoro, Alpine 4, Australis Capital, Mojave Jane UDPATE ... https://ca.proactiveinvestors.com/companies/news/938866/na-proactive-news-snapshotcleanspark-international-montoro-alpine-4-australis-capital-mojave-jane-udpate--938866.html Tue, 19 Jan 2021 22:00:00 -0500 https://ca.proactiveinvestors.com/companies/news/938866/na-proactive-news-snapshotcleanspark-international-montoro-alpine-4-australis-capital-mojave-jane-udpate--938866.html Algernon Pharmaceuticals set for Phase 3 Ifenprodil coronavirus trial after go-ahead from DSMB https://ca.proactiveinvestors.com/companies/news/938848/algernon-pharmaceuticals-set-for-phase-3-ifenprodil-coronavirus-trial-after-go-ahead-from-dsmb-938848.html Tue, 19 Jan 2021 16:01:00 -0500 https://ca.proactiveinvestors.com/companies/news/938848/algernon-pharmaceuticals-set-for-phase-3-ifenprodil-coronavirus-trial-after-go-ahead-from-dsmb-938848.html Algernon Pharmaceuticals lead drug Ifenprodil named as potential COVID-19 treatment in European scientific journal https://ca.proactiveinvestors.com/companies/news/938075/algernon-pharmaceuticals-lead-drug-ifenprodil-named-as-potential-covid-19-treatment-in-european-scientific-journal-938075.html Mon, 11 Jan 2021 14:02:00 -0500 https://ca.proactiveinvestors.com/companies/news/938075/algernon-pharmaceuticals-lead-drug-ifenprodil-named-as-potential-covid-19-treatment-in-european-scientific-journal-938075.html Algernon Pharmaceuticals projects final data from its Ifenprodil COVID-19 trial will be available by end of February as it outlines main aims for 2021 https://ca.proactiveinvestors.com/companies/news/937881/algernon-pharmaceuticals-projects-final-data-from-its-ifenprodil-covid-19-trial-will-be-available-by-end-of-february-as-it-outlines-main-aims-for-2021-937881.html Thu, 07 Jan 2021 14:56:00 -0500 https://ca.proactiveinvestors.com/companies/news/937881/algernon-pharmaceuticals-projects-final-data-from-its-ifenprodil-covid-19-trial-will-be-available-by-end-of-february-as-it-outlines-main-aims-for-2021-937881.html Algernon rapidly advances Ifenprodil as a potential COVID-19 treatment and for battling respiratory diseases https://ca.proactiveinvestors.com/companies/news/937501/algernon-rapidly-advances-ifenprodil-as-a-potential-covid-19-treatment-and-for-battling-respiratory-diseases-937501.html Wed, 30 Dec 2020 17:26:00 -0500 https://ca.proactiveinvestors.com/companies/news/937501/algernon-rapidly-advances-ifenprodil-as-a-potential-covid-19-treatment-and-for-battling-respiratory-diseases-937501.html Algernon Pharmaceuticals says last patient treated in Phase 2b portion of Ifenprodil trial https://ca.proactiveinvestors.com/companies/news/937379/algernon-pharmaceuticals-says-last-patient-treated-in-phase-2b-portion-of-ifenprodil-trial-937379.html Thu, 24 Dec 2020 17:10:00 -0500 https://ca.proactiveinvestors.com/companies/news/937379/algernon-pharmaceuticals-says-last-patient-treated-in-phase-2b-portion-of-ifenprodil-trial-937379.html Algernon provides additional facts on its interim data for its Phase 2b/3 Ifenprodil COVID-19 study https://ca.proactiveinvestors.com/companies/news/936873/algernon-provides-additional-facts-on-its-interim-data-for-its-phase-2b3-ifenprodil-covid-19-study-936873.html Thu, 17 Dec 2020 16:41:00 -0500 https://ca.proactiveinvestors.com/companies/news/936873/algernon-provides-additional-facts-on-its-interim-data-for-its-phase-2b3-ifenprodil-covid-19-study-936873.html Algernon Pharmaceuticals sees positive trending interim data from Phase 2b/3 study of Ifenprodil https://ca.proactiveinvestors.com/companies/news/936615/algernon-pharmaceuticals-sees-positive-trending-interim-data-from-phase-2b3-study-of-ifenprodil-936615.html Tue, 15 Dec 2020 17:41:00 -0500 https://ca.proactiveinvestors.com/companies/news/936615/algernon-pharmaceuticals-sees-positive-trending-interim-data-from-phase-2b3-study-of-ifenprodil-936615.html Algernon Pharmaceuticals reveals positive trending data from Phase 2b portion of Ifenprodil to treat COVID-19 https://ca.proactiveinvestors.com/companies/news/936609/algernon-pharmaceuticals-reveals-positive-trending-data-from-phase-2b-portion-of-ifenprodil-to-treat-covid-19-936609.html Tue, 15 Dec 2020 16:37:00 -0500 https://ca.proactiveinvestors.com/companies/news/936609/algernon-pharmaceuticals-reveals-positive-trending-data-from-phase-2b-portion-of-ifenprodil-to-treat-covid-19-936609.html Algernon Pharmaceuticals Inc presents at the Proactive One2One virtual investment forum https://ca.proactiveinvestors.com/companies/news/936014/algernon-pharmaceuticals-inc-presents-at-the-proactive-one2one-virtual-investment-forum-936014.html Tue, 08 Dec 2020 21:27:00 -0500 https://ca.proactiveinvestors.com/companies/news/936014/algernon-pharmaceuticals-inc-presents-at-the-proactive-one2one-virtual-investment-forum-936014.html Four high-flying growth companies set to take the stage at Proactive's biggest virtual investor forum to date https://ca.proactiveinvestors.com/companies/news/935757/four-high-flying-growth-companies-set-to-take-the-stage-at-proactive-s-biggest-virtual-investor-forum-to-date-935757.html Mon, 07 Dec 2020 21:15:00 -0500 https://ca.proactiveinvestors.com/companies/news/935757/four-high-flying-growth-companies-set-to-take-the-stage-at-proactive-s-biggest-virtual-investor-forum-to-date-935757.html Algernon Pharmaceuticals to present at Proactive’s One2One virtual investor conference, December 8th https://ca.proactiveinvestors.com/companies/news/935673/algernon-pharmaceuticals-to-present-at-proactives-one2one-virtual-investor-conference-december-8th-935673.html Thu, 03 Dec 2020 17:58:00 -0500 https://ca.proactiveinvestors.com/companies/news/935673/algernon-pharmaceuticals-to-present-at-proactives-one2one-virtual-investor-conference-december-8th-935673.html Algernon Pharmaceuticals: Meet the team stepping up to develop a potential COVID-19 treatment https://ca.proactiveinvestors.com/companies/news/935421/algernon-pharmaceuticals-meet-the-team-stepping-up-to-develop-a-potential-covid-19-treatment-935421.html Tue, 01 Dec 2020 19:42:00 -0500 https://ca.proactiveinvestors.com/companies/news/935421/algernon-pharmaceuticals-meet-the-team-stepping-up-to-develop-a-potential-covid-19-treatment-935421.html NA Proactive news snapshot: Milestone Scientific, Loncor Resources, LeanLife, Genprex, BioSig Technologies UPDATE... https://ca.proactiveinvestors.com/companies/news/935261/na-proactive-news-snapshot-milestone-scientific-loncor-resources-leanlife-genprex-biosig-technologies-update-935261.html Mon, 30 Nov 2020 22:00:00 -0500 https://ca.proactiveinvestors.com/companies/news/935261/na-proactive-news-snapshot-milestone-scientific-loncor-resources-leanlife-genprex-biosig-technologies-update-935261.html Algernon Pharmaceuticals enrolls final patient in Phase 2b/3 human study of Ifenprodil https://ca.proactiveinvestors.com/companies/news/935281/algernon-pharmaceuticals-enrolls-final-patient-in-phase-2b3-human-study-of-ifenprodil-935281.html Mon, 30 Nov 2020 19:47:00 -0500 https://ca.proactiveinvestors.com/companies/news/935281/algernon-pharmaceuticals-enrolls-final-patient-in-phase-2b3-human-study-of-ifenprodil-935281.html Algernon Pharmaceuticals says the 168th and final patient enrolled in Phase 2b/3 human study of ifenprodil to treat COVID-19 https://ca.proactiveinvestors.com/companies/news/935253/algernon-pharmaceuticals-says-the-168th-and-final-patient-enrolled-in-phase-2b3-human-study-of-ifenprodil-to-treat-covid-19-935253.html Mon, 30 Nov 2020 14:36:00 -0500 https://ca.proactiveinvestors.com/companies/news/935253/algernon-pharmaceuticals-says-the-168th-and-final-patient-enrolled-in-phase-2b3-human-study-of-ifenprodil-to-treat-covid-19-935253.html NA Proactive news snapshot: CytoDyn, Humanigen, Killi, Great Panther Mining UPDATE… https://ca.proactiveinvestors.com/companies/news/934669/na-proactive-news-snapshot-cytodyn-humanigen-killi-great-panther-mining-update-934669.html Mon, 23 Nov 2020 22:05:00 -0500 https://ca.proactiveinvestors.com/companies/news/934669/na-proactive-news-snapshot-cytodyn-humanigen-killi-great-panther-mining-update-934669.html Algernon Pharma hits milestone in Phase 2b/3 human study of Ifenprodil enrolling 154th patient https://ca.proactiveinvestors.com/companies/news/934687/algernon-pharma-hits-milestone-in-phase-2b3-human-study-of-ifenprodil-enrolling-154th-patient-934687.html Mon, 23 Nov 2020 16:55:00 -0500 https://ca.proactiveinvestors.com/companies/news/934687/algernon-pharma-hits-milestone-in-phase-2b3-human-study-of-ifenprodil-enrolling-154th-patient-934687.html Algernon Pharmaceuticals enrolls 154 patients so far in multinational Phase 2b/3 study of Ifenprodil to treat COVID-19 https://ca.proactiveinvestors.com/companies/news/934651/algernon-pharmaceuticals-enrolls-154-patients-so-far-in-multinational-phase-2b3-study-of-ifenprodil-to-treat-covid-19-934651.html Mon, 23 Nov 2020 13:36:00 -0500 https://ca.proactiveinvestors.com/companies/news/934651/algernon-pharmaceuticals-enrolls-154-patients-so-far-in-multinational-phase-2b3-study-of-ifenprodil-to-treat-covid-19-934651.html Algernon Pharmaceuticals receives tax refund for Australian clinical study on Ifenprodil https://ca.proactiveinvestors.com/companies/news/934065/algernon-pharmaceuticals-receives-tax-refund-for-australian-clinical-study-on-ifenprodil-934065.html Mon, 16 Nov 2020 13:59:00 -0500 https://ca.proactiveinvestors.com/companies/news/934065/algernon-pharmaceuticals-receives-tax-refund-for-australian-clinical-study-on-ifenprodil-934065.html NA Proactive news snapshot: Empower Clinics, Marrone Bio, Phunware, Fidelity Minerals UPDATE… https://ca.proactiveinvestors.com/companies/news/933487/na-proactive-news-snapshot-empower-clinics-marrone-bio-phunware-fidelity-minerals-update-933487.html Mon, 09 Nov 2020 22:15:00 -0500 https://ca.proactiveinvestors.com/companies/news/933487/na-proactive-news-snapshot-empower-clinics-marrone-bio-phunware-fidelity-minerals-update-933487.html Algernon Pharmaceuticals will provide interim data from Ifenprodil Phase 2b/3 human study https://ca.proactiveinvestors.com/companies/news/933505/algernon-pharmaceuticals-will-provide-interim-data-from-ifenprodil-phase-2b3-human-study-933505.html Mon, 09 Nov 2020 20:59:00 -0500 https://ca.proactiveinvestors.com/companies/news/933505/algernon-pharmaceuticals-will-provide-interim-data-from-ifenprodil-phase-2b3-human-study-933505.html Algernon to share interim data from Phase 2b/3 human study of Ifenprodil to treat COVID-19 in December https://ca.proactiveinvestors.com/companies/news/933481/algernon-to-share-interim-data-from-phase-2b3-human-study-of-ifenprodil-to-treat-covid-19-in-december-933481.html Mon, 09 Nov 2020 14:59:00 -0500 https://ca.proactiveinvestors.com/companies/news/933481/algernon-to-share-interim-data-from-phase-2b3-human-study-of-ifenprodil-to-treat-covid-19-in-december-933481.html NA Proactive news snapshot: Medexus Pharmaceuticals, Next Green Wave, Humanigen, Canada Silver Cobalt Works, American Resources UPDATE... https://ca.proactiveinvestors.com/companies/news/932831/na-proactive-news-snapshot-medexus-pharmaceuticals-next-green-wave-humanigen-canada-silver-cobalt-works-american-resources-update-932831.html Fri, 30 Oct 2020 20:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/932831/na-proactive-news-snapshot-medexus-pharmaceuticals-next-green-wave-humanigen-canada-silver-cobalt-works-american-resources-update-932831.html Algernon Pharmaceuticals gets green light from data and safety board to continue Phase 2b-3 study https://ca.proactiveinvestors.com/companies/news/932854/algernon-pharmaceuticals-gets-green-light-from-data-and-safety-board-to-continue-phase-2b-3-study-932854.html Fri, 30 Oct 2020 18:23:00 -0400 https://ca.proactiveinvestors.com/companies/news/932854/algernon-pharmaceuticals-gets-green-light-from-data-and-safety-board-to-continue-phase-2b-3-study-932854.html Algernon wins Data and Safety Monitoring Board approval to continue its Phase 2b/3 human study of Ifenprodil to treat COVID-19 https://ca.proactiveinvestors.com/companies/news/932817/algernon-wins-data-and-safety-monitoring-board-approval-to-continue-its-phase-2b3-human-study-of-ifenprodil-to-treat-covid-19-932817.html Fri, 30 Oct 2020 12:48:00 -0400 https://ca.proactiveinvestors.com/companies/news/932817/algernon-wins-data-and-safety-monitoring-board-approval-to-continue-its-phase-2b3-human-study-of-ifenprodil-to-treat-covid-19-932817.html Algernon announces 25% enrollment for its Phase 2 idiopathic pulmonary fibrosis and chronic cough study of Ifenprodil https://ca.proactiveinvestors.com/companies/news/931325/algernon-announces-25-enrollment-for-its-phase-2-idiopathic-pulmonary-fibrosis-and-chronic-cough-study-of-ifenprodil-931325.html Tue, 13 Oct 2020 13:15:00 -0400 https://ca.proactiveinvestors.com/companies/news/931325/algernon-announces-25-enrollment-for-its-phase-2-idiopathic-pulmonary-fibrosis-and-chronic-cough-study-of-ifenprodil-931325.html Algernon Pharmaceuticals names Dr Mark Swaim to its medical and scientific advisory board https://ca.proactiveinvestors.com/companies/news/931115/algernon-pharmaceuticals-names-dr-mark-swaim-to-its-medical-and-scientific-advisory-board-931115.html Fri, 09 Oct 2020 12:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/931115/algernon-pharmaceuticals-names-dr-mark-swaim-to-its-medical-and-scientific-advisory-board-931115.html Algernon enrolls 100 patients for its Phase 2b/3 human study of Ifenprodil to treat COVID-19 https://ca.proactiveinvestors.com/companies/news/930254/algernon-enrolls-100-patients-for-its-phase-2b3-human-study-of-ifenprodil-to-treat-covid-19-930254.html Tue, 29 Sep 2020 14:14:00 -0400 https://ca.proactiveinvestors.com/companies/news/930254/algernon-enrolls-100-patients-for-its-phase-2b3-human-study-of-ifenprodil-to-treat-covid-19-930254.html Algernon enrolls 50% of patients in multinational Phase 2b/3 human study of Ifenprodil to treat coronavirus https://ca.proactiveinvestors.com/companies/news/929697/algernon-enrolls-50-of-patients-in-multinational-phase-2b3-human-study-of-ifenprodil-to-treat-coronavirus-929697.html Tue, 22 Sep 2020 13:19:00 -0400 https://ca.proactiveinvestors.com/companies/news/929697/algernon-enrolls-50-of-patients-in-multinational-phase-2b3-human-study-of-ifenprodil-to-treat-coronavirus-929697.html